The wearable technology, developed by PhD candidate Deepti Aggarwal at The University of Melbourne, was trialled with three patients and a physiotherapist at the Royal Children’s Hospital, from February to June 2017.
Background images and video below.
A rotavirus vaccine that can be given days after birth has been developed by Australian and Indonesian researchers.
Rotavirus is the common cause of severe diarrhoea and a killer of approximately 215,000 children under five globally each year.
The oral vaccine, called RV3-BB, was given in three single doses, the first within five days of birth. Until now, the vaccine against rotavirus was available in Australia and only on the private market in Indonesia, and could only be administered from six weeks of age.
After three doses of RV3-BB administered from birth:
The success of the RV3-BB vaccine is the culmination of more than four decades of work, which started with the Murdoch Children’s Research Institute’s Professor Ruth Bishop and the discovery of rotavirus in 1973.
The trial was funded by the National Health and Medical Research Council (NHMRC), Bill & Melinda Gates Foundation and PT BioFarma.
Read the full media release on the MCRI website.
Read an earlier story on the work in our Stories of Indonesia-Australia Innovation collection from 2016.
Women in Indonesia were 21 times more likely to die from childbirth than women in Australia in 2015. Many pregnant women in Indonesia, particularly in remote areas, do not regularly visit health clinics and so complications are not detected and dealt with early enough.
World TB Day on March 24 reminds us of the growing TB threat
Scientists available for interview in English and Bahasa Indonesia for World TB Day. Read the release in Bahasa Indonesia.
More images below.
Two proteins from the tuberculosis bacterium have shown promising results in investigations in mice for a new vaccine. Scientists from the Centenary Institute and the University of Sydney, with colleagues at Universitas Gadjah Mada (UGM) in Yogyakarta, have found that the injected proteins can prime the immune system to induce protection against TB in mice.
The team has established a laboratory and immunological techniques to test if the two proteins from the tuberculosis bacterium can be used as the basis for a vaccine. Credit: Centenary Institute
Hari TB Sedunia (25 Maret) mengingatkan kita mengenai ancaman TB yang terus meningkat
Vaksin-vaksin yang lebih baik dibutuhkan agar dapat melawan TB di tingkat global. Global Fund melaporkan sekitar 9 juta kasus TB baru muncul setiap tahunnya, menempati posisi kedua sebagai penyakit menular paling mematikan di dunia setelah AIDS. Menurut Badan Kesehatan Dunia (WHO), lebih dari 320.000 kasus TB dilaporkan di Indonesia pada 2014. Sementara, hanya lebih dari 1.000 kasus TB yang dilaporkan di Australia. Namun, munculnya penyakit TB yang bersifat resistan terhadap obat menimbulkan ancaman bagi seluruh dunia.
An Australian company has completed a trifecta of tools to help Australians take care of their own hearing without the stress and expense of audiology visits. It’s the product of decades of government-backed research. [continue reading…]
Perth researchers have shown that twice-weekly exercise can improve sexual function in prostate cancer patients by 50 per cent.
Now, they’re calling on Perth men to participate in a new study to find out why exercise works, and how effective it can be on a broader range of patients.
One in six Australian men will be diagnosed with prostate cancer, and 90 per cent of them will report some form of sexual dysfunction during or after their treatment.
“Men think about sex a lot – on average, every 45 minutes which is more often than they think about food or sleep,” says Dr Prue Cormie, a senior research fellow at Edith Cowan University. “So it’s not surprising that sexual dysfunction is the most frequently identified issue of importance among prostate cancer survivors.”
Last year, Prue and her colleagues at the Edith Cowan University Health and Wellness Institute put a group of men with prostate cancer through a supervised exercise program involving twice-weekly group-based sessions of resistance exercise such as weight lifting, and aerobic exercises including walking and cycling.
Driving along the Pamir Highway in Tajikistan at 4000 m above sea level or through the Mongolian desert is a far cry from working on the genetics of hepatitis C in a laboratory in central Sydney.
But that’s the transition Wil d’Avigdor, a PhD student from the Liver Injury and Cancer Laboratory at the Centenary Institute is about to make in the next few weeks. [continue reading…]
Here’s some highlights of what’s coming up over the next few days/weeks.
After “astonishing” preliminary results from new drugsAs the burden of Hepatitis C (HCV) associated liver failure and liver cancer rises in our community so hepatitis C therapy is undergoing radical and rapid change, says Centenary’s Prof Geoff McCaughan. [continue reading…]
Follow us on your preferred platform:
